Millennium cuts R&D, manufacturing

- Last updated on GMT

Related tags: United states

Millennium Pharmaceuticals has said that it plans to cut around 600
jobs and wind down some of its manufacturing operations as it seeks
to reach profitability by 2006

One of the USA's leading biotechnology firms, Millennium Pharmaceuticals, has said that it plans to cut around 600 jobs and wind down some of its manufacturing operations as it seeks to reach profitability by 2006.

The company said that it will reduce its headcount by 26 per cent to 1,700 and refocus its resources on development and commercialisation, rather than drug discovery. Moreover, Millennium plans to cease R&D operations completely at its sites in South San Francisco, California, and Cambridge, UK, in order to bring all future development operations under one roof at its headquarters in Cambridge, Massachusetts.

The reduction in the company's headcount will be achieved primarily through reductions in research, many in connection with early-stage discovery collaborations, and in general and administrative functions.

Related products

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Follow us

Products

View more

Webinars